3D Tissue Models

Drug Design: Sanofi-Aventis

Total Score People Score Events Score
19 19 13
Date Event Presentation Speakers
November 3, 2010 DIA’s 8th Annual Canadian Meeting: “Keeping Canada on the Map: Fostering Innovation and Access to Drugs in Canada� Social Media and Its Impact on Clinical Trials Deirdre Cozier
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit China's Pharmaceutical Industry from the Insiders' Eyes Frank Jiang
Marc Cluzel, Ph.D., M.D. Sanofi-Aventis' Strategies for 2010 and Beyond - Reorganizing and Adapting R&D for the Changing Pharmaceutical Industry Marc Cluzel
3 Working with the Scientific Community for Innovative Drugs Alex Zhang
4 Clinical Data Management in China: Opportunities and Challenges Li Ding
4 Project Management in the New Paradigm: Global Clinical Development in Asia Barbara Zhang
4 Chairperson's Opening Remarks Frank Jiang
4 Building a State-of-the-Art Clinical Development Center in China and Ensuring Efficient Site Management Frank Jiang
November 13, 2009 Globalization and standardization: Agreements-Budget-Regulation-Operations. New Presentation Shyard Wong
September 29, 2009 Paediatric Drug Development Developing and implementing successful preclinical studies for first in children trials Nigel Room
May 11, 2009 Patient Recruitment in Clinical Trials Case Study: Recruitment and Retention Planning at the Site Level Kim Hirsch
March 23, 2009 Marketing and Salesforce Effectiveness Under the Revised PhRMA Code MARKETING AND SALES COLLABORATION Nicholas Cutrone
March 3, 2009 2nd annual Competitive Intelligence in Pharma Monitoring competitor pipelines Friederike Brugger Wirtz
Roundtable sessions : Identifying and assessing novel approaches to CI Friederike Brugger Wirtz
February 23, 2009 2nd Annual Latin America Clinical Trials Opportunities for Success in Non-Traditional Latin America Markets Oscar Garcia
February 23, 2009 Advances and Progress in Drug Design VIII X-RAY CRYSTALLOGRAPHY AND OTHER METHODS OF COMPOUND VALIDATION Ulrich Wendt
December 2, 2008 2nd Annual:Outsourcing Preclinical Development Academic / Sponsor relationships: An alternative to CROs? Kenneth Hastings,
November 20, 2008 5TH LATIN AMERICAN CONGRESS OF CLINICAL RESEARCH REGIONAL PERSPECTIVES AND FUTURE TRENDS H) Health economics outcomes. How to measure them? Xavier , . Mesrobian
H) Strategies for patient recruitment and retention. Nancy Augensen
November 26, 2007 Obesity Drug Development World 2007 Morning coffee Antonio Tataranni
Increased efficacy with Rimonabant: evaluating the novel approach with Cannabinoid 1 receptor Antonio Tataranni
Forthcoming Cannabinoid-1 receptor blockers Antonio Tataranni
Fostering regulatory approval for furthering obesity drug research and development Douglas Greene
November 7, 2007 Bridging the Business Development/Alliance Management Interface Nov(7-8) The AM / BD Interface in a Large Pharma / Small Biotech Alliance: Working to Align and Maximize Project Efficiency (15:00-15:40) Kimberly Brue
Bridging the Business Development/Alliance Management GAP and Beyond: GOVERNANCE AND PERFORMANCE - A Panel Discussion (11:50-12:50) Kimberly Brue
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.